Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
RMD
ResMed
$271.05
Login to display ResMed (RMD) recommendation from the last 90 days from financial news and social media. Chart
$277.05 (-2.17%)
$256.61 (+5.63%)
$243.09 (+11.50%)
$240.71 (+12.60%)
RMD has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
RMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
RMD Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RMD Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayRMD Earnings
The TTM reflects 12-month period, providing review of RMD financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is RMD current stock price?
What are RMD stock strengths?
What risks are associated with RMD stock?
When is RMD next earnings report?
What is RMD market cap and volume?
What is RMD's current Stock IQ?
Should I buy RMD stock right now?
Is RMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for RMD?
What does a 'Strong Sell' rating mean for RMD?
What factors influence RMD's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
RMD
ResMed
Current Price
$271.05
Stock Insights
Not Enough Information
Login to view ResMed (RMD) recommendation from the last 90 days from financial news and social media.
Chart
$277.05 (-2.17%)
$256.61 (+5.63%)
$243.09 (+11.50%)
$240.71 (+12.60%)
RMD Analysts Opinion
RMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
RMD Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RMD Street view is extremely bullish and have negative views on the near-term outlook
RMD has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayRMD Earnings
The TTM data reflects the most recent 12-month period, providing overview of RMD financial performance.
RMD Financial Health
The company financial health has moderately improved over the past year
Financial Score
RMD Latest Analysis
Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight. Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 |. DelveInsightThe global wearable medical devices market is experiencing rapid growth driven by the increasing burden of chronic diseases the adoption of remote patient monitoring and swift technological progress. Equipped with compact sensors AI-powered analytics and 5G connectivity these devices are transi
Thu Sep 25, 2025
ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript.
Tue Sep 23, 2025
Citigroup Initiates Coverage of ResMed (RMD) with Buy Recommendation. Fintel reports that on September 18 2025 Citigroup initiated coverage of ResMed (NYSE:RMD) with a Buy recommendation.
Thu Sep 18, 2025
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings). Analysts'. ratings for ResMed (NYSE:) over the last quarter vary from ish to bearish as provided by 9 analysts.The table below provides a snapshot of their recent ratings showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.2520010000000001320002000In the assessment of 12-month price targets analysts unveil insights for ResMed presenting an average target of $294.11 a high esti
Thu Sep 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings